gsk189075
Showing 1 - 11 of 11
Diabetes, Type 1 Trial in San Diego (GSK189075, )
Completed
- Diabetes Mellitus, Type 1
- GSK189075
- placebo
-
San Diego, CaliforniaGSK Investigational Site
Sep 8, 2017
Diabetes, Type 2 Trial in Argentina, Germany, United States (GSK189075, Metformin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK189075
- +2 more
-
Miami, Florida
- +3 more
Sep 1, 2017
Diabetes, Type 2 Trial in Buffalo (GSK189075, Bupropion, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK189075
- +2 more
-
Buffalo, New YorkGSK Investigational Site
Aug 23, 2017
Diabetes, Type 2, Obesity Trial in Cambridge (GW869682, GSK189075, GSK189075-Placebo)
Completed
- Diabetes Mellitus, Type 2
- Obesity
- GW869682
- +3 more
-
Cambridge, Cambridgeshire, United KingdomGSK Investigational Site
Aug 4, 2017
Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK189075
- Placebo
-
Mesa, Arizona
- +156 more
Sep 26, 2017
Diabetes, Type 2 Trial in Worldwide (GSK189075, pioglitazone, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK189075
- +2 more
-
Mesa, Arizona
- +135 more
Nov 2, 2017
Type 2 Diabetes, Diabetes, Type 2 Trial in Miramar (GSK189075, Brevicon)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- GSK189075
- Brevicon
-
Miramar, FloridaGSK Investigational Site
May 31, 2012
Type 2 Diabetes, Diabetes, Type 2 Trial in Columbus (ketoconazole, GSK189075)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- ketoconazole
- GSK189075
-
Columbus, OhioGSK Investigational Site
May 31, 2012
Type 2 Diabetes, Diabetes, Type 2 Trial in Madison (GSK189075)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- GSK189075
-
Madison, WisconsinGSK Investigational Site
May 31, 2012
Type 2 Diabetes, Diabetes, Type 2 Trial in Madison (GSK189075)
Completed
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2
- GSK189075
-
Madison, WisconsinGSK Investigational Site
Mar 15, 2012
Type 2 Diabetes, Diabetes, Type 2, Renal Insufficiency Trial in United States (GSK189075)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- GSK189075
-
Orlando, Florida
- +3 more
Mar 15, 2012